MedPath

Comparing outcome between oral tranexamic acid 250mg with 35 percent Glycolic acid peels versus oral tranexamic acid with low fluency q switched nd-yag laser

Phase 4
Conditions
Health Condition 1: L00-L99- Diseases of the skin and subcutaneous tissue
Registration Number
CTRI/2024/06/069086
Lead Sponsor
Deekshitha
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
ot Yet Recruiting
Sex
Not specified
Target Recruitment
0
Inclusion Criteria

All people under age group 18 to 60 are included

Exclusion Criteria

Age less than 18 ,pregnancy, lactation, increased Bt,Ct, Pt-inr, using oral contraceptives pills ,pre existing inflammation dermatoses-atopic dermatitis ,systemic lupus ervthematosus, photo dermatoses, active infections, h/o contact dermatitis to glycolic acid products, thromboembolism, h/o intake of drugs with photosensitizing potential ,patients with keloid tendencies, patients with unrealistic expectations

Study & Design

Study Type
Interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Secondary Outcome Measures
NameTimeMethod
© Copyright 2025. All Rights Reserved by MedPath